RESUMEN
The clinical expert consensus statement on takotsubo syndrome (TTS) part II focuses on the diagnostic workup, outcome, and management. The recommendations are based on interpretation of the limited clinical trial data currently available and experience of international TTS experts. It summarizes the diagnostic approach, which may facilitate correct and timely diagnosis. Furthermore, the document covers areas where controversies still exist in risk stratification and management of TTS. Based on available data the document provides recommendations on optimal care of such patients for practising physicians.
Asunto(s)
Cardiomiopatía de Takotsubo/diagnóstico , Cardiomiopatía de Takotsubo/terapia , Algoritmos , Arritmias Cardíacas/etiología , Angiografía por Tomografía Computarizada , Angiografía Coronaria , Manejo de la Enfermedad , Ecocardiografía , Electrocardiografía , Humanos , Imagen por Resonancia Magnética , Imagen de Perfusión Miocárdica , Recurrencia , Cardiomiopatía de Takotsubo/complicaciones , Resultado del TratamientoRESUMEN
Takotsubo syndrome (TTS) is a poorly recognized heart disease that was initially regarded as a benign condition. Recently, it has been shown that TTS may be associated with severe clinical complications including death and that its prevalence is probably underestimated. Since current guidelines on TTS are lacking, it appears timely and important to provide an expert consensus statement on TTS. The clinical expert consensus document part I summarizes the current state of knowledge on clinical presentation and characteristics of TTS and agrees on controversies surrounding TTS such as nomenclature, different TTS types, role of coronary artery disease, and etiology. This consensus also proposes new diagnostic criteria based on current knowledge to improve diagnostic accuracy.
Asunto(s)
Cardiomiopatía de Takotsubo/diagnóstico , Cardiomiopatía de Takotsubo/fisiopatología , Distribución por Edad , Catecolaminas/metabolismo , Enfermedad de la Arteria Coronaria/fisiopatología , Vasoespasmo Coronario/fisiopatología , Humanos , Trastornos Mentales/epidemiología , Microcirculación , Enfermedades del Sistema Nervioso/epidemiología , Placa Aterosclerótica/fisiopatología , Factores de Riesgo , Distribución por Sexo , Cardiomiopatía de Takotsubo/epidemiología , Cardiomiopatía de Takotsubo/metabolismo , Terminología como AsuntoRESUMEN
The 2017 focused update of the 2013 ACC/AHA guideline on heart failure contains new and important recommendations on prevention, novel biomarker uses, heart failure with preserved ejection fraction (HFpEF), and comorbidities such as hypertension, iron deficiency, and sleep-disordered breathing. Potential implications for management of acute decompensated heart failure will also be explored.